瑞士Biosynth于2022年3月17日完成對美國Vivitide的收購,更好的服務于生物制藥與診斷試劑行業(yè)
關于Vivitide
Vivitide由New England Peptide(成立于1998年)和Peptides International(成立于1983年)于2019年合并而成,總部位于馬薩諸塞州加德納,在肯塔基州路易斯維爾開展重要業(yè)務。 vivitide致力于提供卓越的產品質量和客戶服務,為全球學術界、制藥、生物技術和診斷公司提供廣泛的肽、抗體和生化產品,以及肽合成、抗體定制服務。Vivitide擁有從mg級到kg級的制造能力,此外,在復雜肽合成(如RGD肽)方面擁有獨特的專業(yè)知識。
Vivitide生產一些特殊產品包括:RGD肽、TrypTides(用于蛋白質組學研究的胰蛋白酶肽)、穩(wěn)定同位素標記的肽和氨基酸、各種受體激動劑和拮抗劑(包括 PAR、GLP-1、NPY、緩激肽、生長素釋放肽)、鐵調素、細胞穿透肽、大環(huán)肽、酶抑制劑和底物(包括:TAPI、FRET、MMP、蛋白酶)、生物標志物、點擊化學產品、mini-PEG? solubilizing linkers、CLEAR-OX? 聚合物支持的氧化劑和組合肽。
希凱生物是瑞士Biosynth授權簽約代理商
更多vivitide產品信息,請聯(lián)系北京希凱創(chuàng)新科技有限公司獲得
貨號 | CAS號 | 產品名稱 |
PAR-3677-PI | 3-Mercaptopropionyl-Phe-Cha-Cha-Arg-Lys-Pro-Asn-Asp-Lys-NH2 | |
CKG-23008-V | 1193251-95-4 | 7-Alkynyl-Fucose Tetraacetate |
PCN-4311-V | 156467-85-5 | Alpha-Conotoxin ImI |
PCN-4140-V | 83481-45-2 | Alpha-Conotoxin MI |
PCN-4228-V | 115797-06-3 | Alpha-Conotoxin SI |
PED-3788-PI | 103900-19-2 | BQ-788 Sodium Salt |
PBK-4002 | Bradykinin (Human, Bovine, Rat, Mouse) | |
PCT-4494-V | 1906866-53-2 | Candidalysin |
PCK-4176-S | 67256-27-3 | CCK-33 (Porcine) |
PCK-4083 | 5609-49-4 | CCK-Tetrapeptide (30-33) |
PCK-4083-V | 35144-91-3 | CCK-Tetrapeptide (30-33) |
PBP-4511-V | CLE25 Peptide | |
PCT-4240-S | CNP-53 (Porcine, Rat) | |
PCT-4241-S | 141294-77-1 | CNP-53, human |
PCN-4329-V | 937031-00-0 | Cortistatin (Rat) |
PNM-3410-V | CPN-267 | |
PCI-3917-PI | Cyclo(Arg-Ala-Asp-D-Tyr-Cys) | |
PCI-3894-PI | Cyclo(Arg-Ala-Asp-D-Tyr-Lys) | |
PCI-3912-PI | Cyclo(Arg-Gly-Asp-D-Tyr-Cys) | |
PCI-3953-PI | Cyclo(Arg-Gly-Glu-D-Phe-Lys) | |
PCI-3959-PI | Cyclo[Arg-Ala-Asp-D-Phe-Lys(Ac-SCH2CO)] | |
PCI-3808-PI | Cyclo[Arg-Ala-Asp-D-Phe-Lys(Biotin-PEG-PEG)] | |
PCI-3954-PI | Cyclo[Arg-Ala-Asp-D-Phe-Lys(PEG-PEG)] | |
PCI-3699-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(Ac-SCH2CO)] | |
PCI-3697-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(Biotin-PEG-PEG)] | |
PCI-3895-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(Biotin)] | |
PCI-3790-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(dPEG?4)] | |
PCI-3898-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(H-Ser)] | |
PCI-3977-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-COCH2CH2SH)] | |
PCI-3823-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG-Cys)] | |
PCI-3696-PI | Cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG)] | |
PKA-002 | Cytidine Monophosphate Kinase 1 , human, recombinant | |
PDC-4269-S | Decorsin | |
PCI-3903-PI | DOTA-Glu-[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 | |
CYT-340 | Flt3 Ligand Mouse | |
ENZ-454 | Fructose-1,6-Bisphosphatase 1, human, recombinant | |
CYT-305 | GDNF Human | |
PCI-3930-PI | H-Arg-Ala-Asp-Ser-Lys-OH | |
PCI-3929-PI | H-Arg-Gly-Asp-Ser-Lys-OH | |
PCI-3979-PI | H-Glu[Cyclo(Arg-Ala-Asp-D-Phe-Lys)]2 | |
PCI-3904-PI | H-Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 | |
PCI-3899-PI | H-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2 | |
PCI-3975-PI | H-Glu{Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2 | |
PCI-3965-PI | H-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Ser-Pro-OH | |
PAR-3673-PI | H-Gly-Tyr-Pro-Gly-Gln-Val-NH2 | |
PCP-3922-PI | H-Lys-Val-Pro-Arg-Asn-Gln-Asp-Trp-Leu-OH | |
PCI-3963-PI | H-Pro-His-Ser-Arg-Asn-OH | |
PAR-3925-PI | H-Thr-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-NH2 | |
HSP-014 | HSP-70 Cofactor (HSP24) E.coli (recombinant) | |
ENZ-323 | Hyaluronidase | |
ENZ-499 | Hydroxyacyl-Coenzyme A Dehydrogenase, human, recombinant | |
CYT-295 | IGF1 Gilthead Seabream | |
CYT-289 | IGF1 Rat | |
CYT-375 | IL 13 Mouse | |
CYT-378 | IL 17 Mouse | |
CYT-370 | IL 2 Mouse | |
CYT-684 | IL 21 Mouse | |
CYT-483 | IL 4 Human, His | |
CYT-254 | IL 7 Human | |
CYT-372 | IL 7 Mouse | |
CYT-506 | Leptin Dog | |
CYT-351 | Leptin Mouse | |
PBC-4144 | Leu-Pro-Leu-Arg-Phe-NH2 diacetate dihydrate | |
ENZ-317 | Matrix Metalloproteinase-13, human, recombinant | |
PCN-4440-V | Mu-Conotoxin SIIIA | |
PNM-4496-S | Neuromedin S (Mouse) | |
PKA-034 | Nucleoside Diphosphate Kinase E.coli (recombinant) | |
CYT-501 | PDGF BB Human | |
CYT-586 | TFF1 Human | |
ENZ-649 | Thymine-DNA Glycosylase, human, recombinant | |
CYT-443 | TRAIL Human | |
PDF-4271-S | α-Defensin-1, human | |
PDF-4337-S | β-Defensin-1, human | |
PDF-4338-S | β-Defensin-2, huma |